CHRISTUS Health is expanding treatment options for men suffering from benign prostate hyperplasia, commonly known as enlarged prostate, with the addition of Aquablation therapy, a “minimally invasive” procedure, combining the precision of robotic technology with the power of a high-pressure water jet to remove excess prostate tissue causing urinary symptoms. The Aquablation uses a non-thermal approach reportedly designed to preserve surrounding tissue while effectively relieving obstructions.
Touted benefits of Aquablation include a reduced risk of urinary incontinence, better preservation of sexual function by avoiding heat-related nerve damage, and a lower risk of significant bleeding, with transfusion rates of less than 1%.
“One of the biggest advantages of Aquablation is precision,” CHRISTUS Health Urologist Dr. J Denton Harris said. “The procedure is done using real-time ultrasound imaging and artificial intelligence to map the prostate. This allows us to remove only the tissue causing blockage while minimizing the risk of damage to surrounding structures.”
Harris added that, “Many men assume urinary symptoms are simply a normal part of aging, but they don't have to live with them.
“Aquablation gives us the ability to effectively treat enlarged prostates while helping preserve the quality-of-life factors that matter most to patients.”
.